EVOLVE IS SOLVING DYSBIOSIS OF THE NEWBORN GUT MICROBIOME Learn more about Evivo®, the first probiotic clinically proven to restore the infant gut microbiome VISIT EVIVO.COM Evolve BioSystems is dedicated to developing the next generation of products to establish, restore, and maintain a healthy newborn gut microbiome. Building on a decade of expertise in the partnership between the infant gut microbiome and human breast milk, Evolve is solving newborn gut dysbiosis, or an imbalance of beneficial bacteria, through microbiome-based interventions in both human and animal health. CAREERS We are hiring! Check out our open positions. NEWS & EVENTS New research is first to show how key gut bacterium trains infant immune system Jun 17, 2021 Study published in cell reveals critical role of activated B. infantis EVC001 in using human milk to program immune cells early in life to control inflammation and autoimmune disease risk New study reports reductions in diaper rash and colic as well as improvement in sleep in infants following supplementation with the specific gut bacterium activated B. infantis EVC001 Jun 8, 2021 Researchers publishing today in the peer-reviewed science journal Beneficial Microbes reported that three common infant health issues associated with Newborn Gut Deficiency – diaper rash, colic and sleep problems – were substantially reduced or eliminated altogether within days of introducing a key beneficial gut bacterium that is missing in more than 90% of all babies in the U.S. Evolve BioSystems, Inc. Announces the Use of Activated B. infantis EVC001 by International Consortium to Study the Prevention of Type 1 Diabetes in Children Mar 11, 2021 Study is led by the Institute for Diabetes Research at Helmholtz Zentrum München and conducted by the Global Platform for the Prevention of Autoimmune Diabetes New study reports activated B. infantis EVC001 improves health outcomes in preterm infants Feb 16, 2021 Study quantifies unprecedented reduction in enteric inflammation, diaper rash and antibiotic use via beneficial gut remodeling Evolve BioSystems Announces Major Strategic Investment from Cargill and Manna Tree to Support Innovative Probiotic That Dramatically Improves Infant Gut Health Feb 8, 2021 Evolve’s innovative probiotic addresses widespread Newborn Gut Deficiency by restoring key bacteria in the infant gut microbiome New study: Nine out of ten U.S. infants experience gut microbiome deficiency Jan 21, 2021 Largest study to date benchmarks widespread, underrecognized microbiome-linked risk to infant immune system development, antibiotic resistance, acute conditions such as colic and diaper rash Genetic analysis of B. infantis strains reveal functional superiority of activated EVC001 in infants Oct 27, 2020 Unique mechanism of action of the probiotic bacteria B. infantis EVC001 allows for full utilization of human milk and maximizes benefit in the infant gut. New Study: Infant Gut Health Must Focus on Microbiome Function, Not Diversity Apr 15, 2020 This publication provides a firm, objective definition of gut dysbiosis based on biological function, not diversity. As such, Evolve Bio has set a new bar for evaluating the health of the infant gut and established a path by which clinicians can more effectively assess the impact of medical interventions and specific probiotics. Infant Fecal pH Revealed as a Critical Indicator of Infant Gut Health and Resistance against Gut Pathogen Invasion Apr 15, 2020 Our new publication demonstrates that the previously established infant fecal pH reference range provided an inaccurate view of a baby’s gut health, masking the risk of overabundance of pathogenic gut bacteria during a critical period of immune system development. RB and Evolve BioSystems Team Up to Advance Infant Gut Health Dec 5, 2019 Today RB and Evolve BioSystems announce a partnership in the sale of Evivo®, Evolve Biosystems’ infant probiotic. CONTACT Evolve BioSystems mailing address: 2121 2nd St., Suite C108 Davis, CA 95618 info@evolvebiosystems.com GET STARTED Home About Science News Resources Careers NEWSLETTER Stay up to date with Evolve. Subscribe SUBSCRIBE © 2019 EVOLVE BIOSYSTEMS. ALL RIGHTS RESERVED. TERMS | PRIVACY POLICY